1-6 of 6
Constantin G. Ioannides
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02

George E. Peoples, Jarrod P. Holmes, Matthew T. Hueman, Elizabeth A. Mittendorf, Asna Amin, Steven Khoo, Zia A. Dehqanzada, Jennifer M. Gurney, Michael M. Woll, Gayle B. Ryan, Catherine E. Storrer, Dianna Craig, Constantin G. Ioannides, Sathibalan Ponniah
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 797–803.
https://doi.org/10.1158/1078-0432.CCR-07-1448
Published: 01 February 2008
View articletitled, Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02
Open the PDF for Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02 in another window
Journal Articles

Synthetic MicroRNA Designed to Target Glioma-Associated Antigen 1 Transcription Factor Inhibits Division and Induces Late Apoptosis in Pancreatic Tumor Cells

Naotake Tsuda, Satoshi Ishiyama, Yufeng Li, Constantin G. Ioannides, James L. Abbruzzese, David Z. Chang
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (21): 6557–6564.
https://doi.org/10.1158/1078-0432.CCR-06-0588
Published: 03 November 2006
View articletitled, Synthetic MicroRNA Designed to Target Glioma-Associated Antigen 1 Transcription Factor Inhibits Division and Induces Late Apoptosis in Pancreatic Tumor Cells
Open the PDF for Synthetic MicroRNA Designed to Target Glioma-Associated Antigen 1 Transcription Factor Inhibits Division and Induces Late Apoptosis in Pancreatic Tumor Cells in another window
Includes: Supplementary data
Journal Articles

Clinical Studies of Vaccines Targeting Breast Cancer

Byung K. Ko, Kouichiro Kawano, James L. Murray, Mary L. Disis, Clay L. Efferson, Henry M. Kuerer, George E. Peoples, Constantin G. Ioannides
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3222–3234.
Published: 05 September 2003
View articletitled, Clinical Studies of Vaccines Targeting Breast Cancer
Open the PDF for Clinical Studies of Vaccines Targeting Breast Cancer in another window
Journal Articles

Toxicity, Immunogenicity, and Induction of E75-specific Tumor-lytic CTLs by HER-2 Peptide E75 (369–377) Combined with Granulocyte Macrophage Colony-stimulating Factor in HLA-A2+ Patients with Metastatic Breast and Ovarian Cancer

James L. Murray, Michael E. Gillogly, Donna Przepiorka, Hannah Brewer, Nuhad K. Ibrahim, Daniel J. Booser, Gabriel N. Hortobagyi, Andrzej P. Kudelka, Kenneth H. Grabstein, Martin A. Cheever, Constantin G. Ioannides
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (11): 3407–3418.
Published: 01 November 2002
View articletitled, Toxicity, Immunogenicity, and Induction of E75-specific Tumor-lytic CTLs by HER-2 Peptide E75 (369–377) Combined with Granulocyte Macrophage Colony-stimulating Factor in HLA-A2+ Patients with Metastatic Breast and Ovarian Cancer
Open the PDF for Toxicity, Immunogenicity, and Induction of E75-specific Tumor-lytic CTLs by HER-2 Peptide E75 (369–377) Combined with Granulocyte Macrophage Colony-stimulating Factor in HLA-A2+ Patients with Metastatic Breast and Ovarian Cancer in another window
Journal Articles

Peptide Priming of Cytolytic Activity to HER-2 Epitope 369–377 in Healthy Individuals

Brett W. Anderson, George E. Peoples, James L. Murray, Michael A. Gillogly, David M. Gershenson, Constantin G. Ioannides
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (11): 4192–4200.
Published: 01 November 2000
View articletitled, Peptide Priming of Cytolytic Activity to HER-2 Epitope 369–377 in Healthy Individuals
Open the PDF for Peptide Priming of Cytolytic Activity to HER-2 Epitope 369–377 in Healthy Individuals in another window
Journal Articles

Vaccine Implications of Folate Binding Protein, a Novel Cytotoxic T Lymphocyte-recognized Antigen System in Epithelial Cancers

George E. Peoples, Brett W. Anderson, Tom V. Lee, James L. Murray, Andrezj P. Kudelka, J. Taylor Wharton, Constantin G. Ioannides
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 4214–4223.
Published: 01 December 1999
View articletitled, Vaccine Implications of Folate Binding Protein, a Novel Cytotoxic T Lymphocyte-recognized Antigen System in Epithelial Cancers
Open the PDF for Vaccine Implications of Folate Binding Protein, a Novel Cytotoxic T Lymphocyte-recognized Antigen System in Epithelial Cancers in another window